Kyoungho Suk Selected Research

KT 15073

1/2010

Identification of KT-15073 as an inhibitor of lipopolysaccharide-induced microglial activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyoungho Suk Research Topics

Disease

47	Neuroinflammatory Diseases 10/2022 - 08/2006
31	Inflammation (Inflammations) 10/2022 - 06/2003
19	Neuroblastoma 05/2015 - 02/2007
18	Neoplasms (Cancer) 12/2020 - 02/2007
17	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 10/2003
13	Brain Injuries (Brain Injury) 01/2021 - 10/2003
11	Hypothermia 01/2019 - 01/2011
9	Glioma (Gliomas) 12/2020 - 01/2002
9	Pain (Aches) 01/2018 - 08/2013
9	Hypersensitivity (Allergy) 12/2016 - 12/2005
8	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 06/2010
8	Ischemia 03/2016 - 04/2002
7	Hypoxia (Hypoxemia) 05/2015 - 10/2002
6	Cognitive Dysfunction 12/2021 - 06/2011
6	Gliosis 01/2019 - 01/2009
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 03/2015
4	Infections 01/2021 - 02/2008
4	Nervous System Diseases (Neurological Disorders) 01/2020 - 04/2012
4	Parkinson Disease (Parkinson's Disease) 01/2020 - 11/2011
4	Brain Ischemia (Cerebral Ischemia) 12/2012 - 04/2002
4	Necrosis 07/2012 - 11/2006
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2022 - 03/2013
3	Optic Neuritis (Retrobulbar Neuritis) 05/2022 - 06/2015
3	Obesity 12/2021 - 06/2015
3	Cerebellar Ataxia (Dysmetria) 04/2021 - 01/2020
3	Diabetic Neuropathies (Diabetic Neuropathy) 01/2021 - 01/2016
3	Leukemia 01/2020 - 12/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 05/2013
3	Stroke (Strokes) 05/2013 - 01/2011
3	Astrocytoma (Pilocytic Astrocytoma) 03/2010 - 10/2006
3	Atherosclerosis 06/2009 - 11/2006
3	Atherosclerotic Plaque (Atheroma) 06/2009 - 11/2006
2	Hypertension (High Blood Pressure) 12/2021 - 02/2005
2	Ataxia (Dyssynergia) 04/2021 - 11/2020
2	Normal Pressure Hydrocephalus 01/2021 - 08/2014
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 07/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 03/2019
2	Infarction (Infarctions) 01/2019 - 01/2004
2	hypoglycemic encephalopathy 01/2019 - 01/2019
2	Neuralgia (Stump Neuralgia) 01/2018 - 08/2013
2	Brain Diseases (Brain Disorder) 01/2016 - 04/2010
2	Wounds and Injuries (Trauma) 02/2015 - 01/2014
2	Fibrosarcoma 07/2012 - 10/2010
2	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 06/2011 - 01/2010

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
25	CytokinesIBA 01/2022 - 12/2005
20	Lipocalin-2IBA 05/2022 - 01/2009
19	Pharmaceutical PreparationsIBA 12/2020 - 08/2004
13	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2007
13	Neuroprotective AgentsIBA 04/2021 - 10/2003
12	LipopolysaccharidesIBA 12/2021 - 01/2002
9	Messenger RNA (mRNA)IBA 01/2022 - 04/2002
9	ChemokinesIBA 05/2020 - 11/2006
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016 - 10/2002
7	ProteomeIBA 01/2018 - 04/2010
7	NF-kappa B (NF-kB)IBA 10/2010 - 12/2005
6	Small Interfering RNA (siRNA)IBA 10/2022 - 12/2007
6	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 10/2013
6	Pyruvic Acid (Pyruvate)IBA 01/2021 - 10/2013
6	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 11/2020 - 10/2013
6	Biological ProductsIBA 02/2015 - 07/2007
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2012 - 01/2002
5	Peptides (Polypeptides)IBA 10/2022 - 06/2011
5	Phosphotransferases (Kinase)IBA 12/2020 - 03/2016
5	LigandsIBA 06/2019 - 11/2006
5	Oxygen (Dioxygen)IBA 03/2016 - 01/2004
4	IronIBA 01/2021 - 01/2015
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2010
4	Lactic Acid (Lactate)FDA LinkGeneric 09/2016 - 10/2013
4	EnzymesIBA 03/2016 - 11/2006
4	p38 Mitogen-Activated Protein KinasesIBA 12/2005 - 10/2002
3	Therapeutic UsesIBA 11/2020 - 02/2013
3	Fatty Acids (Saturated Fatty Acids)IBA 05/2020 - 01/2017
3	Sodium AzideIBA 03/2019 - 03/2010
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019 - 12/2013
3	Freund's AdjuvantIBA 10/2015 - 04/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2013 - 03/2012
3	Alkylating AgentsIBA 03/2012 - 12/2009
3	Carmustine (FIVB)FDA Link 03/2012 - 12/2009
3	Immunoglobulin E (IgE)IBA 02/2011 - 12/2005
2	Immunoglobulin G (IgG)IBA 05/2022 - 05/2013
2	AcidsIBA 01/2021 - 11/2020
2	Chitinase-3-Like Protein 1IBA 01/2021 - 12/2011
2	ChitinasesIBA 01/2021 - 12/2011
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 10/2010
2	InterferonsIBA 01/2020 - 12/2007
2	LipidsIBA 01/2017 - 11/2006
2	NeurotoxinsIBA 10/2016 - 07/2008
2	Formaldehyde (Formol)FDA Link 01/2016 - 12/2013
2	LipocalinsIBA 01/2016 - 06/2015
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2013 - 01/2011
2	decursinIBA 07/2012 - 10/2010
2	IntegrinsIBA 03/2012 - 05/2011
2	Complementary DNA (cDNA)IBA 05/2011 - 12/2009
2	p-Methoxy-N-methylphenethylamineIBA 02/2011 - 05/2010

Therapy/Procedure

8	Induced Hypothermia 11/2013 - 05/2011
6	Therapeutics 04/2021 - 12/2009
3	Drug Therapy (Chemotherapy) 01/2016 - 12/2009
2	Spinal Injections 10/2022 - 08/2013
2	Decompressive Craniectomy 01/2019 - 06/2014